During the Lightning Round segment of Mad Money callers get a chance to ask Jim Cramer about stocks they are interested in. One caller Thursday night asked Cramer about Calithera Biosciences Inc. (CALA) : "This is a speculative stock but a good spec," replied Cramer about the clinical-stage biopharmaceutical company.
The company work on small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity, according to its website.
Let's check out the charts because I certainly do not understand the science.
In the daily bar chart of CALA, below, we can see that prices made a low in October and a higher low in March. Prices have crossed above and below and above the moving averages again but the slope of the 200-day moving average line has turned up slightly.
The On-Balance-Volume (OBV) line shows an interesting and potential bullish movement. The line bottomed in October and was very steady in March when prices declined. It seems like buyers of CALA used the March pullback to buy shares.
The Moving Average Convergence Divergence (MACD) oscillator crossed to the upside last month for a cover shorts buy signal and this indicator is now close to crossing the zero line.